Unexplained Infertility

Unexplained infertility means a couple has not conceived after a year of regular, unprotected intercourse, yet every standard test comes back normal. Ovulation is happening, the fallopian tubes are open, and the semen analysis is fine. It accounts for roughly 15% to 30% of infertility cases that reach a full evaluation, according to a StatPearls clinical review. It is a diagnosis of exclusion, not a disease in itself.

The word "unexplained" can feel frustrating. It does not mean nothing is wrong. It means the cause sits below the resolution of the tests we routinely run. In India, professional bodies estimate that about one in five infertile couples fall into the unexplained or shared-cause group, with male and female factors each making up around 40%.

Unexplained infertility is not the absence of a cause. It is the absence of a cause that current standard tests can detect. Most couples with this label still have a meaningful chance of conceiving, with or without treatment, and the choice between waiting, IUI, and IVF depends heavily on the woman's age and how long you have been trying.

Even when standard tests are normal, subtle problems can quietly lower the chance of pregnancy each month. Routine tests measure whether systems work at a basic level, not how well they work together.

Likely hidden contributors include reduced egg quality that does not yet show on hormone tests, sperm that look normal under a microscope but carry DNA fragmentation, eggs and sperm that struggle to fertilise, and embryos that fail to implant in the uterine lining. Mild endometriosis or early tubal dysfunction may also escape detection. Age is the single biggest unmeasured factor, since egg quality declines steadily after the mid-30s even when periods stay regular.

Unexplained does not mean unfixable. It means the cause is too subtle for today's tests, and treatment can still raise your odds month by month.

Unexplained infertility usually has no symptoms beyond the difficulty conceiving itself. Periods are regular, ovulation predictors turn positive, and there is no pain or unusual bleeding. That is exactly what makes the diagnosis so confusing for many couples.

The defining "sign" is statistical, not physical: 12 months of regular, well-timed intercourse without a pregnancy, dropping to 6 months if the woman is 35 or older. Because there are no warning signs, the only way to reach this diagnosis is to complete a thorough workup and find every result within the normal range.

Unexplained infertility can only be confirmed after a complete, normal workup, so the quality of the diagnosis depends entirely on how thorough the testing was. The 2023 ESHRE guideline defines it as infertility with normal ovulation, normal tubes, and a normal semen analysis.

A proper evaluation confirms ovulation (usually a mid-luteal progesterone), checks ovarian reserve (AMH and antral follicle count), confirms the fallopian tubes are open (an HSG or sonohysterography), and includes a recent semen analysis read against WHO criteria. If any of these were skipped or done years ago, the label "unexplained" may simply mean "under-investigated." It is reasonable to ask which tests were done before accepting the diagnosis.

Standard Diagnostic Tests in India

• Mid-luteal progesterone — A blood test about a week before the expected period confirms that ovulation is occurring.
• Ovarian reserve testing (AMH + AFC) — Anti-Mullerian hormone and an antral follicle count estimate the remaining egg supply.
• Tubal patency check — Hysterosalpingography (HSG) or saline sonohysterography confirms the fallopian tubes are open.
• Semen analysis — Assesses sperm count, motility, and morphology against WHO criteria; ideally repeated if borderline.
• Pelvic ultrasound — Looks for fibroids, polyps, ovarian cysts, or signs of endometriosis that routine exams miss.

Couples with unexplained infertility usually have a reduced, not absent, monthly chance of conceiving, and the prognosis is genuinely better than many fear. In the TUI trial, 9% of women in the watchful-waiting arm had a live birth within three cycles without any treatment, which shows natural conception still happens.

The two factors that matter most are the woman's age and how long you have been trying. Younger couples and shorter durations carry a better outlook, because subtle egg-quality issues weigh less heavily. As age rises and the trying-time lengthens, the monthly odds fall, which is why guidelines push toward active treatment sooner for women in their late 30s.

• Reduced, not absent, monthly chance: The odds of conceiving each cycle are lower than expected, but natural pregnancy still happens, as the TUI trial's 9% birth rate with no treatment showed.
• Age drives the prognosis: Egg quality declines after the mid-30s even with regular periods, so a woman's age is the strongest predictor of success.
• Duration matters: The longer you have been trying without success, the lower the spontaneous monthly chance, which is why guidelines escalate treatment over time.
• Treatable with good outcomes: Both stimulated IUI and IVF substantially raise live birth rates over watchful waiting, so the long-term outlook is encouraging for most couples.

Treatment for unexplained infertility is a stepwise escalation, and guidelines from NICE and ESHRE disagree on exactly when to start, so the right path is individualised. The three main steps are expectant management (continuing to try), ovarian stimulation with intrauterine insemination (IUI), and IVF.

The 2023 ESHRE guideline recommends IUI combined with ovarian stimulation as first-line treatment, ideally with low-dose drugs to limit the risk of multiples. NICE NG257 (2026) takes a more conservative line for the UK, advising couples to keep trying for a total of two years before IVF and not routinely offering IUI or oral stimulation drugs alone. In India, where IVF is paid out of pocket, many couples start with a few cycles of stimulated IUI because it is far cheaper, then move to IVF if it fails.

1. Confirm the diagnosis. Make sure the workup was complete: ovulation, ovarian reserve, tubal patency, and a recent semen analysis all normal.
2. Expectant management. For younger couples trying under 2 years, a planned period of timed intercourse is reasonable, since natural conception still occurs.
3. Stimulated IUI. ESHRE recommends 3 cycles of IUI with low-dose ovarian stimulation as first-line active treatment. The TUI trial showed 31% live births vs 9% with waiting.
4. IVF. If IUI fails, or for older women and longer durations, move to IVF. NICE advises offering IVF after 2 years of trying.

IVF is often very effective for unexplained infertility, but it is not automatically better than IUI for everyone. A 2024 individual participant data meta-analysis in Human Reproduction Update pooled four trials and found cumulative live birth rates of 50.3% with IVF versus 43.2% with stimulated IUI, a difference that was not statistically significant.

What IVF does offer is information. By watching whether eggs fertilise and embryos develop in the lab, the clinic may finally uncover the hidden factor, such as poor fertilisation or weak embryo quality, that the normal workup missed. NICE recommends offering up to three full IVF cycles to eligible women under 40. For Indian couples, the practical question is usually cost and time: IVF reaches a result faster, while IUI is gentler on the budget. Both are reasonable, evidence-backed choices.